UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 16, 2024 4:30 P.M.
Form:
F-3
CIK:
0001598599
Company Name:
Innate Pharma SA
File Number:
333-276164